Sara Grethlein, MD, MBA, is a hematologist and medical oncologist serving as Chief Medical Officer for the Clinical Institutes, Puget Sound at Providence Swedish and Executive Medical Director of the Swedish Cancer Institute, where she leads clinical strategy, program development, and quality-focused, patient-centered oncology care. Her clinical work centers on comprehensive medical oncology and hematology, complex diagnostic and therapeutic care for blood and bone marrow conditions, and the development of integrated, multidisciplinary cancer programs. Her research interests include precision oncology enabled by artificial intelligence and multi-omic approaches, expanding equitable access to clinical trials through remote monitoring and decentralized models, and advancing medical education and cost-conscious care to support clinicians and improve system performance. Dr. Grethlein has been recognized with the Sandra Turner Excellence in Clinical Research Award and has held major physician-executive leadership roles across academic and health system settings, including prior faculty service at Indiana University School of Medicine with a focus on resident education. She earned her MD from SUNY Downstate Health Sciences University College of Medicine, completed an internal medicine residency at Barnes-Jewish Hospital/Washington University in St. Louis, and completed fellowship training in hematology and medical oncology at Barnes-Jewish Hospital/Washington University in St. Louis, and later earned an MBA from Indiana University’s Kelley School of Business.
Chief Medical Officer
Medical School
1984 – 1988
Residency
1988 – 1991
Fellowship
1991 – 1994